Lewes, Delaware â June 26, 2014 â (Techsonian) â Halozyme Therapeutics, (NASDAQ:HALO), reported that it recently presented a scientific poster highlighting the CONSISTENT 1 trial results at the 74th Scientific Sessions of the American Diabetes ... ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home